A
Angelo Santoliquido
Researcher at Catholic University of the Sacred Heart
Publications - 114
Citations - 3400
Angelo Santoliquido is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Medicine & Endothelial dysfunction. The author has an hindex of 29, co-authored 102 publications receiving 2874 citations. Previous affiliations of Angelo Santoliquido include Sapienza University of Rome & The Catholic University of America.
Papers
More filters
Journal ArticleDOI
Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development
Maria Assunta Zocco,Enrico Di Stasio,Raimondo De Cristofaro,Marialuisa Novi,Maria Elena Ainora,Francesca Romana Ponziani,Laura Riccardi,Stefano Lancellotti,Angelo Santoliquido,Roberto Flore,Maurizio Pompili,Gian Ludovico Rapaccini,Paolo Tondi,Giovanni Gasbarrini,Raffaele Landolfi,Antonio Gasbarrini +15 more
TL;DR: Lower concentrations of natural coagulation inhibitors are frequently detected in patients with liver cirrhosis and a reduced portal flow velocity seems to be the most important predictive variable for PVT development in patientsWith cirrhotic patients.
Journal ArticleDOI
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth
Gabriella Nucera,Maurizio Gabrielli,Andrea Lupascu,Ernesto Cristiano Lauritano,Angelo Santoliquido,Filippo Cremonini,Giovanni Cammarota,P. Tondi,Paolo Pola,Giovanni Gasbarrini,Antonio Gasbarrini +10 more
TL;DR: The lactulose breath test is a reliable and non‐invasive test for the diagnosis of small intestinal bacterial overgrowth and sugar malabsorption and may play a role in irritable bowel syndrome.
Journal ArticleDOI
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome
Andrea Lupascu,Maurizio Gabrielli,Ernesto Cristiano Lauritano,Emidio Scarpellini,Angelo Santoliquido,Giovanni Cammarota,Roberto Flore,P. Tondi,Paolo Pola,Giovanni Gasbarrini,Antonio Gasbarrini +10 more
TL;DR: No data exist on small intestinal bacterial overgrowth prevalence in a significant population of healthy non‐irritable bowel syndrome subjects, and differences in criteria to define irritable bowel Syndrome patients and methods to assess small intestinal bacteria overgrowth may explain different results.
Journal ArticleDOI
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.
Ernesto Cristiano Lauritano,Maurizio Gabrielli,Andrea Lupascu,Angelo Santoliquido,Gabriella Nucera,Emidio Scarpellini,F. Vincenti,Giovanni Cammarota,Roberto Flore,Paolo Pola,Giovanni Gasbarrini,Antonio Gasbarrini +11 more
TL;DR: A small number of controlled studies assessing choice and duration of antibiotic therapy for small intestinal bacterial overgrowth are available and these studies suggest that using antibiotics for this purpose is a viable treatment option.
Journal ArticleDOI
Exercise and Protein Intake: A Synergistic Approach against Sarcopenia.
Anna Maria Martone,Emanuele Marzetti,Riccardo Calvani,Anna Picca,Matteo Tosato,Luca Santoro,Angela Di Giorgio,Antonio Nesci,Alex Sisto,Angelo Santoliquido,Francesco Landi +10 more
TL;DR: The randomized clinical trial conducted within SPRINTT will provide robust evidence on the effectiveness of exercise and nutrition at preventing negative outcomes associated with sarcopenia and physical frailty.